ABSTRACT
Multifunctional optical materials can be realized by combining stimuli-responsive photoluminescence (PL), e.g., optical thermometry, with non-linear optical (NLO) effects, such as second-harmonic generation (SHG). We report a novel approach towards SHG-active luminescent thermometers achieved by constructing unique iridium(iii) complexes, cis-[IrIII(CN)2(R,R-pinppy)2]- (R,R-pinppy = (R,R)-2-phenyl-4,5-pinenopyridine), bearing both a chiral 2-phenylpyridine derivative and cyanido ligands, the latter enabling the formation of a series of molecular materials: (TBA)[IrIII(CN)2(R,R-pinppy)2]·2MeCN (1) (TBA+ = tetrabutylammonium) and (nBu-DABCO)2[IrIII(CN)2(R,R-pinppy)2](i)·MeCN (2) (nBu-DABCO+ = 1-(n-butyl)-1,4-diazabicyclo-[2.2.2]octan-1-ium) hybrid salts, (TBA)2{[LaIII(NO3)3(H2O)0.5]2[IrIII(CN)2(R,R-pinppy)2]2} (3) square molecules, and {[LaIII(NO3)2(dmf)3][IrIII(CN)2(R,R-pinppy)2]}·MeCN (4) coordination chains. Thanks to the chiral pinene group, 1-4 crystallize in non-centrosymmetric space groups leading to SHG activity, while the N,C-coordination of ppy-type ligands to Ir(iii) centers generates visible charge-transfer (CT) photoluminescence. The PL characteristics are distinctly temperature-dependent which was utilized in achieving ratiometric optical thermometry below 220 K. The PL phenomena were rationalized by DFT/TD-DFT calculations indicating an MLCT-type of the emission in obtained Ir(iii) complexes with the rich vibronic structure providing a few emission bands that variously depend on temperature due to the role of thermally activated vibrations. As these crucial vibrational modes depend on the crystal lattice, the thermometry performance differs within 1-4 being the most efficient in 4 while the SHG is by far the best also for 4. This proves that pinene-functionalized cyclometalated dicyanidoiridates(iii) are great prerequisites for tunable PL-NLO conjunction with the most effective multifunctionality ensured by the insertion of these anions into bimetallic frameworks.
ABSTRACT
BACKGROUND: The use of immunotherapeutic vaccination in prostate cancer is a promising approach that likely requires the induction of functional, cytotoxic T cells . The experimental approach described here uses a well-studied adenovirus-poxvirus heterologous prime-boost regimen, in which the vectors encode a combination of prostate cancer antigens, with the booster dose delivered by either the intravenous or intramuscular (IM) route. This prime-boost regimen was investigated for antigen-specific CD8+ T cell induction. METHODS: The coding sequences for four antigens expressed in prostate cancer, 5T4, PSA, PAP, and STEAP1, were inserted into replication-incompetent chimpanzee adenovirus Oxford 1 (ChAdOx1) and into replication-deficient modified vaccinia Ankara (MVA). In four strains of mice, ChAdOx1 prime was delivered intramuscularly, with an MVA boost delivered by either IM or intravenous routes. Immune responses were measured in splenocytes using ELISpot, multiparameter flow cytometry, and a targeted in vivo killing assay. RESULTS: The prime-boost regimen was highly immunogenic, with intravenous administration of the boost resulting in a sixfold increase in the magnitude of antigen-specific T cells induced and increased in vivo killing relative to the intramuscular boosting route. Prostate-specific antigen (PSA)-specific responses were dominant in all mouse strains studied (C57BL/6, BALBc, CD-1 and HLA-A2 transgenic). CONCLUSION: This quadrivalent immunotherapeutic approach using four antigens expressed in prostate cancer induced high magnitude, functional CD8+ T cells in murine models. The data suggest that comparing the intravenous versus intramuscular boosting routes is worthy of investigation in humans.
